Gregory D. Flexter
Gründer bei Blue Ash Therapeutics LLC
Ursprung des Netzwerks ersten Grades von Gregory D. Flexter
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986
11
| Extinct | Miscellaneous Commercial Services | 11 |
Blue Ash Therapeutics LLC
Blue Ash Therapeutics LLC BiotechnologyHealth Technology Blue Ash Therapeutics LLC was formed in December 2008 in Cincinnati to bring a promising cardiovascular drug - azimilide - to market. Azimilide is an oral once-daily cardiac ant arrhythmic (AA) drug for use in patients whose life-threatening arrhythmias require an implantable cardioverter-defibrillator (ICD) as a therapy of last resort. Azimilide became available for license upon Procter and Gamble's strategic exit in 2008 and final sell-off of pharmaceuticals assets to Warner Chilcott in October 2009. Blue Ash Therapeutics was formed by former P&G managers with long experience and extensive knowledge of azimilide and what's needed for its approval and market launch. In the first 13 months of its formation Blue Ash Therapeutics has assembled public and private seed-round investments, has been awarded a Third Frontier (GCIC) funding grant, and has secured global License Agreement with current azimilide owners, Warner Chilcott, PLC. The next major phase for Blue Ash Therapeutics will be securing venture-funding for carrying out a final FDA-required clinical trial of azimilide for marketing approval. Blue Ash Therapeutics seeks to commercialize not only azimilide, but to grow into a Cincinnati-based company specializing in acute-care cardiovascular therapies.
5
| Subsidiary | Biotechnology | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Gregory D. Flexter
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Chemicals: Agricultural | Corporate Officer/Principal | |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Medical Specialties | Human Resources Officer | |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Bayer Pharmaceuticals Corp. | Sales & Marketing | ||
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ABCAM PLC | Biotechnology | Director/Board Member | |
SHIRE | Pharmaceuticals: Major | Chief Administrative Officer Chairman Director/Board Member Director/Board Member Corporate Officer/Principal | |
GOOCH & HOUSEGO PLC | Electronic Components | Chief Executive Officer | |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Sales & Marketing | |
Miami University | College/University | Undergraduate Degree | |
Universidad de Buenos Aires | College/University | Doctorate Degree | |
London Business School | College/University | President | |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Wyeth-Ayerst Research | Chief Tech/Sci/R&D Officer | ||
Relmada Therapeutics, Inc. /Old/
Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Relmada Therapeutics, Inc. is a holding company, which engages in the development of pharmaceutical drugs for the treatment of acute and chronic pains. It focuses in the developing of chronic pain due to cancer, musculoskeletal disorders, and peripheral neuropathy. The company was founded in 2000 and is headquartered in Blue Bell, PA. | Pharmaceuticals: Major | President | |
Abbott Pharmaceutical, Inc. | Corporate Officer/Principal | ||
Kent Periscopes Ltd.
Kent Periscopes Ltd. Aerospace & DefenseElectronic Technology Kent Periscopes Ltd. produces unity vision periscopes for armoured fighting vehicles. Its products include K6 unity vision periscope, EIP BVM Biocular View Module, Sabre NGS Narrow Gunner''s Sight, EIP Biocular and Sabre Ti. The company is headquartered in St. Asap, the United Kingdom. | Aerospace & Defense | Director/Board Member | |
Gooch & Housego (UK) Ltd.
Gooch & Housego (UK) Ltd. Electronic ComponentsElectronic Technology Gooch & Housego (UK) Ltd. engages in the manufacturing of optical and photographic instruments. The company was incorporated on July 28, 2006 and is headquartered in Illminster, the United Kingdom. | Electronic Components | Director/Board Member | |
G&H US Holdings Ltd.
G&H US Holdings Ltd. Financial ConglomeratesFinance Part of Gooch & Housego Plc, G & H US Holdings Ltd. functions as an investment holding British company. The company is based in Somerset, UK. | Financial Conglomerates | Director/Board Member | |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Bio Products Laboratory Ltd. manufactures blood plasma products. It offers products that are classified in human coagulation factors, human immunoglobulins, and human albumin solutions. The company was founded on August 11, 1950 and is headquartered in Elstree, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
CICap Ltd.
CICap Ltd. Financial ConglomeratesFinance CICap Ltd. is an investment holding British company founded in 1993. The private company is based in London, UK. The company's main function is to hold investments. | Financial Conglomerates | Director/Board Member | |
Spanoptic Ltd.
Spanoptic Ltd. Electronic ComponentsElectronic Technology Founded in 1976, Spanoptic Ltd is one of the largest independent manufacturers of optical components in the United Kingdom. Based in Scotland, Spanoptic produces a broad range of custom designed optics made from various materials expanding from Ultraviolet to Infrared. With their experienced team and advanced technology they are able to produce precision optical components of superior quality at competitive price. They closely liaise with customers at all project levels and are aiming for absolute customer satisfaction. Spanoptic provides in-depth understanding of precision optics from design to fabrication with dedication to applications in the aerospace, security, defence, machine vision and health care & life science industry. | Electronic Components | Director/Board Member | |
The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
RELMADA THERAPEUTICS, INC. | Pharmaceuticals: Major | President | |
Phoenixus AG
Phoenixus AG Pharmaceuticals: MajorHealth Technology Phoenixus AG operates as a research-based pharmaceutical company. It develops and commercializes treatments for diseases and conditions with limited or no treatment options. The firm's products include Daraprim and Vecamyl. The company was founded by Martin Shkreli on February 24, 2015 and is headquartered in Baar, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Vyera Pharmaceuticals LLC
Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
School of Pharmacy (CONNECTICUT) | College/University | Undergraduate Degree | |
Abbott Laboratories, Inc.
Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | Medical Specialties | Corporate Officer/Principal | |
PASSAGE BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
New World Laboratories | Chief Tech/Sci/R&D Officer | ||
Gooch & Housego Torquay Ltd.
Gooch & Housego Torquay Ltd. Electronic Production EquipmentElectronic Technology Part of Gooch & Housego Plc, Gooch & Housego Torquay Ltd. is a British company that designs and manufactures electronic and fiber optic components and modules. The company is based in Illminster, UK. | Electronic Production Equipment | Director/Board Member |
Statistik
International
Vereinigte Staaten | 29 |
Vereinigtes Königreich | 13 |
Kanada | 4 |
Irland | 3 |
Frankreich | 3 |
Sektoral
Health Technology | 31 |
Consumer Services | 8 |
Electronic Technology | 6 |
Finance | 3 |
Process Industries | 2 |
Operativ
Director/Board Member | 60 |
Corporate Officer/Principal | 32 |
Chief Tech/Sci/R&D Officer | 17 |
Independent Dir/Board Member | 15 |
Chairman | 14 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Gregory D. Flexter
- Unternehmensverbindungen